Lucy Scientific Discovery Inc. (OTCPK: LSDI.F)
Health Care · Pharmaceuticals · CA
$0.00
— today · -50.0% 1Y
Lucy Scientific Discovery Inc. (OTCPK: LSDI.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $176.00 and employs 2 people.
Over the last twelve months the share price has lost 50.0%, trading between 0.00 and 0.02.
Tweenvest scores Lucy Scientific Discovery Inc. across four factors: quality 16/100, value 45/100. Its strongest factor is value.
LSDI.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $176.00
- Revenue (TTM)
- $16.73K
- P/E
- —
- EPS
- -6.94
- Dividend yield
- —
- Beta (5Y)
- -27.57
- 52-week high
- $0.02
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.76M
- Employees
- 2
- Next earnings
- —
About Lucy Scientific Discovery Inc.
Lucy Scientific Discovery Inc. researches, develops, manufactures, and commercializes psychedelic products. It offers biological raw materials, crude extracts, psychotropic compounds, and active pharmaceutical ingredients (APIs). Lucy Scientific Discovery Inc. was formerly known as Hollyweed North Cannabis, Inc. The company was incorporated in 2017 and is based in Victoria, Canada.
- Founded
- 2017
- Listed since
- Feb 9, 2023
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,238.28 | -1.36% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.96 | +0.27% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $149.49 | -2.01% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.20 | -1.70% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.54 | -1.52% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.89 | -0.66% |
Figures last refreshed Aug 18, 2026.